StonvexLoading…
StonvexCore line items from BFS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $289.84M | $268.85M | $257.21M | $245.86M |
Operating Income | $195.32M | $203.76M | $189.40M | $180.52M |
Net Income | $37.51M | $50.65M | $52.69M | $50.19M |
EPS (Diluted) | $1.09 | $1.63 | $1.73 | $1.63 |
Total Assets | $2.16B | $2.13B | $1.99B | $1.83B |
Total Liabilities | $1.69B | $1.63B | $1.49B | $1.31B |
Cash & Equivalents | $8.74M | $10.30M | $8.41M | $13.28M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $4.26M |
Shares Outstanding | 24.55M | 24.30M | 24.08M | 24.02M |